| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 31.97 Billion | USD 129.97 Billion | 15.2% | 2024 |
FrequentlyAsked Questions
The global bioprocess technology market is expected to grow due to increasing demand for biopharmaceuticals, advancements in biomanufacturing techniques, and the growing adoption of single-use technologies and automation in bioprocessing.
According to a study, the global bioprocess technology market size was worth around USD 31.97 Billion in 2024 and is expected to reach USD 129.97 Billion by 2034.
The global bioprocess technology market is expected to grow at a CAGR of 15.2% during the forecast period.
North America is expected to dominate the bioprocess technology market over the forecast period.
Leading players in the global bioprocess technology market include Lonza, GE Healthcare (General Electric Company), Thermo Fisher Scientific Inc, Sartorius AG, Eppendorf AG, Dickinson and Company, Becton, Siemens Healthineers, Nova Biomedical, Advanced Instruments, F. Hoffmann-La Roche Ltd., and Danaher Corporation, amon, among others.
The report explores crucial aspects of the bioprocess technology market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients